Loading...
Alendronate sodium and nonsteroidal anti-inflammatory drugs (NSAIDs) are individually associated with endoscopically demonstrated gastric-mucosal injury. To determine the combined effect of these drugs on the upper gastrointestinal tract, these U.S. authors conducted an endoscopist-blind, randomized, crossover trial of alendronate sodium alone, naproxen sodium (an NSAID) alone, and a combination of both drugs. Subjects were 26 healthy volunteers (18 women and 8 men, aged 30 or older). On entry, subjects had endoscopically demonstrated normal gastric and esophageal mucosa; they agreed to abstain from alcohol, caffeine, tobacco, and all other medications during the study. During three 14-day treatment cycles (with a 1- to 4-week washout perio…